Detection of human papilloma virus by «Self sampling»: a new model of cervical cancer screening
DOI:
https://doi.org/10.34287/MMT.4(47).2020.11Abstract
The article presents the advantages of screening cervical cancer based on the detection of oncogenic strains of human papillomavirus compare to traditional cytological screening using the PAP test. Self sampling using Aprovix's Qvintip tool (Sweden) allows to increase the percentage of women participating in national population screening programs, which will lead to an improvement in the incidence and mortality rates of the female population from cervical cancer.
References
Cervical screening: programme overview. Information on the NHS Cervical Screening Programme, including commissioning, quality assurance, education and training. 1 April 2015. Updated 18 November 2019. https://www.gov. uk/guidance/cervical-screening-programmeoverview GOV.UK. Public Health England. Accessed November 20, 2020.
Koss LG, Melamed MR. Koss' Diagnostic Cytology and Its Histopathologic Bases. Lippincott Williams & Wilkins; 2006. 1752 р.
Andrae B, Kemetli L, Sparén P, Screeningpreventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst. 2008; 100: 605–606.
Arbyn M, Castellsagué X, de Sanjosé S et al. Worldwide burden of cervical cancer in 2008. Ann. Oncol. 2011; 22: 2675–2686.
Baseman, JG, Koutsky LA. The epidemiology of human papillomavirus infections. J. Clin. Virol. 2005. 32 (Suppl. 1): S16–S24.
Chow LT, Broker TR, Steinberg BM. The natural history of human papillomavirus infections of the mucosal epithelia. 2010. 118 (6-7): 422–449.
Dhiraj B Nikumbh, Roopali D. Nikumbh, Shivraj N. Kanthikar. Limitations of cytological cervical cancer screening (Papanicolaou test) regarding technical and cultural aspect in rural India. Asian J Cancer. 2016. 5 (2): 79.
Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. 2006. 110: 525–541.
Durst M, Gissmann L, Ikenberg H et al. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl Acad. Sci. USA. 1983. 80: 3812–3815.
Wikström I, Lindell M, Sanner K et al. Selfsampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Br J Cancer. 2011. 105: 337–339.
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Parice: IARC; 2014. 54 р.
IARC. A review of human carcinogens. PartB: biological agents. Parice: IARC; 2011. 2 р.
Jemal A, Bray F, Center MM et al. Global cancer statistics. Cancer J Clin. 2011: 61–69.
Jentschke M, Chen K, Arbyn M. Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections. J Clin Virol. 2016. 82: 46–50.
O'Dowd MJ, Philipp EE. The History of Obstetrics & Gynaecology. Parthenon Publishing Group; 1994. Р. 547.
McCredie MRЕ, Sharples KJ, Paul C et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008. 9: 425–434.
McLaughlin-Drubin ME, Munger K. Viruses associated with human cancer. Biochim. Biophys. Acta. 2008. 1782: 127–150.
Meijer CJ, Berkhof J, Castle PE. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer. 2009. 124: 516–520.
Moore PS, Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat. Rev. Cancer. 2010. 10: 878–889.
Krump NA, You J. Molecular mechanisms of viral oncogenesis in humans. Nature Reviews Microbiology. 2018. 16: 684–698.
Nayar R, Wilbur DC. The Pap Test and Bethesda 2014. Acta Cytologica. 2015. 59: 121–132.
Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. 1999. 354 (9172): 20-25.
Peto J, Gilham C, Fletcher O et al. The cervical cancer epidemic that screening has prevented in the UK. Lancet. 2004. 364: 249–256.
Petry KU, Wörmann B, Schneider A. Benefits and Risks of Cervical Cancer Screening. Oncol Res Treat. 2014. 37 (suppl 3): 48–57.
Petry KU. HPV and cervical cancer. Clin Lab Invest Suppl. 2014. 244: 59–62.
Ronco G, Dillner J, Elfström KM. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014. 383 (9916): 524–532.
Ronco G, Giorgi-Rossi P, Carozzi F. New Technologies for Cervical Cancer screening (NTCC). Lancet Oncol. 2010. 11: 249–257.
Sanner K, Wikström I, Strand A. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br J Cancer. 2009. 101: 871–874.
Saraiya M, Unger ER, Thompson TD et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. l Cancer Inst. 2015. 107 (6, djv086): 1–12.
Snijders PJ, Steenbergen RD, Heideman D et al. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J. Pathol. 2006. 208: 152–164.
Human Papillomaviruses. General remarks. https://www.ncbi.nlm.nih.gov/books/ NBK321764. Accessed November 19, 2020.
Vink MA, Bogaards JA, van Kemenade FJ et al. Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data. Am. J. Epidemiol. 2013. 178: 1161–1169.
Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999. 189 (1): 12–19.
Wikström I, Stenvall H, Wilander E. Attitudes to self-sampling of vaginal smear for human papilloma virus analysis among women not attending organized cytological screening. Acta Obstet Gynecol Scand. 2007. 86: 720–725.
Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organization; 1968. 166 р.
Winkelstein W. Vignettes of the History of Epidemiology: Three Firsts by Janet Elizabeth Lane-Claypon. American Journal of Epidemiology. 2004. 160 (2): 97–101.
Zucchetto A, Ronco G, Giorgi Rossi P et al. Screening patterns within organized programs and survival of Italian women with invasive cervical cancer. Prev Med. 2013. 57: 220–226.
zur Hausen H, de Villiers EM. Cancer “causation” by infections — individual contributions and synergistic networks. Semin. Oncol. 2014. 41: 860–875.
zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl Cancer Inst. 2000. 92: 690–698.
